Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-08-18 17:21:16 ET · period of report 2026-08-17 · accession 0001628280-26-057759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-18 17:21 | 2026-08-17 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $23.23 | -3,040 | 216.4K | -1% | -$70.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | S | D | 3,040 | $23.23 | 216,383.65 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025. (F2) Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026. |